Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04126278
Other study ID # 19-01299
Secondary ID
Status Terminated
Phase Phase 4
First received
Last updated
Start date December 1, 2020
Est. completion date August 23, 2022

Study information

Verified date December 2023
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the efficacy of barbotage therapy by comparing the clinical and sonographic changes in patients that solely receive barbotage to patients receiving the standard of care, barbotage with cortisone injection.


Description:

Calcific tendonitis is a condition caused by calcium deposits building up in a person's muscles or tendons. If calcium builds up in an area, a person may feel pain and discomfort there. The purpose of this study is to determine the efficacy of barbotage therapy (injecting and washing the shoulder joint with saline) by comparing the amount of pain, shoulder function, and X-Rays in patients with calcific tendonitis that receive the standard of care, barbotage with cortisone injection, against barbotage with saline injection. Receiving barbotage without cortisone is therefore considered experimental.


Recruitment information / eligibility

Status Terminated
Enrollment 4
Est. completion date August 23, 2022
Est. primary completion date August 12, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Must be at least 18 years of age and younger than 90 years of age - Diagnosed with calcific tendonitis and ruled out other shoulder-related pathologies - Failed 1st line therapy (physical therapy and cortisone injection) - Intention to receive barbotage with cortisone as standard of care - 3 or more months of shoulder pain - Finding of one or more calcifications =5 mm in size on either sonogram or radiograph, located on the supraspinatus tendon - Positive Hawkin's test or Neer's sign for impingement Exclusion Criteria: - Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.) - Osteoarthritis of the glenohumeral joint of the affected shoulder - Previous surgery or barbotage to the affected shoulder - History of prior allergic/hypersensitivity reactions related to the study medication - Shoulder instability, glenohumeral arthritis, AC pathology, inflammatory arthropathy, fibromyalgia, frozen shoulder or cervical radiculopathy - Sub-acromial injection with a corticosteroid or treatment by ESWT during the last 3 months before inclusion - Younger than 18 years of age or older than 90 - Any patient considered a vulnerable subject

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Barbotage
Administered as per standard of care
Dexamethasone
4 mg of dexamethasone

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analog Scale (VAS) Score at Visit 1 Pain will be assessed by the Visual Analog Scale which describes pain in terms of no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm). Visit 1 (Day 0)
Primary VAS Score at Visit 2 Pain will be assessed by the Visual Analog Scale which describes pain in in terms of no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm). Visit 2 (Week 6)
Primary VAS Score at Visit 3 Pain will be assessed by the Visual Analog Scale which describes pain in terms or sdlk no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm). Visit 3 (Month 3)
Primary VAS Score at Visit 4 Pain will be assessed by the Visual Analog Scale which describes pain in no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm). Visit 4 (Month 6)
Primary QuickDASH Score at Visit 1 Individual's ability to complete tasks, absorb forces, and severity of symptoms are measured by a 11-item QuickDash questionnaire using a 5 point Likert scale. The raw score is the sum of responses and is rescaled into a total score ranging from 0-100; lower scores indicate greater abilities. Visit 1 (Day 0)
Primary QuickDASH Score at Visit 4 Individual's ability to complete tasks, absorb forces, and severity of symptoms are measured by a 11-item QuickDash questionnaire using a 5 point Likert scale. The raw score is the sum of responses and is rescaled into a total score ranging from 0-100; lower scores indicate greater abilities. Visit 4 (Month 6)
Primary American Shoulder and Elbow Surgeons (ASES) Index Score at Visit 1 24-item assessment of pain and daily living related to shoulder conditions. Items are rated on various Likert scales. The raw score is the sum of responses and is converted to a total score. Total scores range from 0 to 100; higher scores indicate a better shoulder condition. Visit 1 (Day 0)
Primary ASES Index Score at Visit 4 24-item assessment of pain and daily living related to shoulder conditions. Items are rated on various Likert scales. The raw score is the sum of responses and is converted to a total score. Total scores range from 0 to 100; higher scores indicate a better shoulder condition. Visit 4 (Month 6)
Primary Radiographic Size of Calcium Deposit at Visit 1 Size of calcium deposit will be assessed with Shoulder X-rays. Visit 1 (Day 0)
Primary Radiographic Size of Calcium Deposit at Visit 4 Size of calcium deposit will be assessed with Shoulder X-rays. Visit 4 (Month 6)
See also
  Status Clinical Trial Phase
Recruiting NCT03779919 - The Therapeutic Effect of the Extracorporeal Shock Wave Therapy on Shoulder Calcific Tendinitis N/A
Recruiting NCT05478902 - Effectiveness of Non-surgical Management in Rotator Cuff Calcific Tendinopathy (THE EFFECT TRIAL) N/A
Completed NCT05272085 - Comparison of the Efficiency of Ultrasound-Guided Lavage and Subacromial Bursa Injection in Calcific Tendinitis N/A
Completed NCT01832376 - Treatment of Calcific Tendinitis by Ultrasound-guided Needle Lavage N/A
Recruiting NCT02367560 - Calcific Tendinitis: Comparing Minimally Invasive Modalities N/A
Completed NCT02173743 - Platelet-rich Plasma in Calcific Tendinitis N/A
Recruiting NCT01538758 - Ultrasound Guided Needling Versus Ultrasound Guided Corticosteroid Injection Alone, a Randomized Controlled Trial. N/A
Recruiting NCT04251832 - Efficacy of Sodium Thiosulfate in Shoulder Pain in Calcific Tendinitis of the Rotator Cuff Phase 2